José Luis Vizmanos

11PUBLICATIONS
20CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsHaematological tumoursMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 08, 2025
A Novel In Vivo Method Using Caenorhabditis elegans to Evaluate α-Glucosidase Inhibition by Natural Products for Type 2 Diabetes Treatment.

María Pilar de Torre, José Luis Vizmanos, Rita Yolanda Cavero

|Nov 09, 2024
Myeloproliferative Neoplasm-like Mutations of Calreticulin Induce Phenotypes Associated with Calreticulin Dysfunction in C. elegans.

Ana Guijarro-Hernández, Cristina Hurtado, Estibaliz Urizar-Compains

|Apr 27, 2024
CALR but Not JAK2 Mutations Are Associated with an Overexpression of Retinoid X Receptor Alpha in Essential Thrombocythemia.

Ana Guijarro-Hernández, Cristina Hurtado, María José Larráyoz

|Oct 25, 2023
Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab.

Cristina Pangua, Socorro Espuelas, María Cristina Martínez-Ohárriz

|Jan 23, 2023
Optimizing simple calreticulin upregulation strategies in Caenorhabditis elegans.

Ana Guijarro-Hernández, Cristina Hurtado, José Luis Vizmanos

|Jan 08, 2023
Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model.

Ana Guijarro-Hernández, Laura Eder-Azanza, Cristina Hurtado

Pageof 2

Frequent Collaborators

5 joint publications

Ana Guijarro-Hernández

3 joint publications

Paula Aranaz

3 joint publications

María Zabala

3 joint publications

Ana Romo-Hualde